NCT03724175 The Role of Secondary Bile Acids in Intestinal Inflammation Status TERMINATED Phase PHASE2/PHASE3
NCT03720002 HF2 Therapy in the Treatment of Active Ulcerative Colitis Status COMPLETED Phase PHASE1/PHASE2
NCT03711006 The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis Status COMPLETED Phase PHASE1/PHASE2
NCT03698500 Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03689673 Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) Status COMPLETED Phase N/A
NCT03679546 EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis Status COMPLETED Phase PHASE4
NCT03675477 A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. Status COMPLETED Phase PHASE2
NCT03671980 IBD Self-management Website and Home Faecal Calprotectin Monitoring Status COMPLETED Phase NA
NCT03669822 Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) Status COMPLETED Phase N/A
NCT03663400 Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples Status COMPLETED Phase N/A
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Status TERMINATED Phase PHASE1
NCT03650413 An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease Status TERMINATED Phase PHASE2
NCT03648398 Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease Status UNKNOWN Phase NA
NCT03643211 Xeljanz Special Investigation for Long-term Use in UC Patients Status COMPLETED Phase N/A
NCT03640637 The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases Status UNKNOWN Phase N/A
NCT03616821 Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT03615690 The Influence of a Fasting Mimicking Diet on Ulcerative Colitis Status RECRUITING Phase NA
NCT03604536 Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis Status TERMINATED Phase N/A